van der Meulen J - Search Results

1

Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.

Verbrugh HA, van Bronswijk H, van der Meulen J, Oe PL, Verhoef J. Verbrugh HA, et al. Among authors: van bronswijk h, van der meulen j. Contrib Nephrol. 1987;57:85-91. Contrib Nephrol. 1987. PMID: 3677705 No abstract available.

2

Host defence in CAPD treatment: the effect of the dialysate on cell function.

van Bronswijk H, Verbrugh HA, Heezius EC, Verkooyen RP, van der Meulen J, Verhoef J. van Bronswijk H, et al. Among authors: van der meulen j. Contrib Nephrol. 1990;85:67-72. doi: 10.1159/000419064. Contrib Nephrol. 1990. PMID: 2078941 Review. No abstract available.

3

Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?

de Fijter CW, Verbrugh HA, Heezius HC, van Bronswijk H, van der Meulen J, Oe PL, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: van bronswijk h, van der meulen j. Adv Perit Dial. 1989;5:124-7. Adv Perit Dial. 1989. PMID: 2577393 Clinical Trial.

4

In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.

de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Verhoef J, Donker AJ. de Fijter CW, et al. Among authors: van der meulen j. Clin Nephrol. 1993 Feb;39(2):75-80. Clin Nephrol. 1993. PMID: 8448921 Clinical Trial.

5

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.

de Fijter CW, Verbrugh HA, Oe LP, Peters ED, van der Meulen J, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: van der meulen j. Kidney Int. 1992 Oct;42(4):947-50. doi: 10.1038/ki.1992.371. Kidney Int. 1992. PMID: 1453585 Free article. Clinical Trial.

6

Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.

de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: van der meulen j. Adv Perit Dial. 1991;7:150-3. Adv Perit Dial. 1991. PMID: 1680413 Clinical Trial.

7

The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.

de Fijter CW, Verbrugh HA, Oe PL, Peters ED, van der Meulen J, Donker AJ, Verhoef J, Lameire N. de Fijter CW, et al. Among authors: van der meulen j. Adv Perit Dial. 1991;7:154-7. Adv Perit Dial. 1991. PMID: 1680414 Clinical Trial.

8

A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD).

de Fijter CW, Oe PL, Nauta JJ, van der Meulen J, ter Wee PM, Snoek FJ, Donker AJ. de Fijter CW, et al. Among authors: van der meulen j. Adv Perit Dial. 1991;7:186-9. Adv Perit Dial. 1991. PMID: 1680422 Clinical Trial.

9

Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients.

Vlaanderen K, Bos HJ, de Fijter CW, Oe LP, van der Meulen J, Verbrugh HA, Beelen RH. Vlaanderen K, et al. Among authors: van der meulen j. Nephron. 1991;57(1):29-35. doi: 10.1159/000186211. Nephron. 1991. PMID: 2046812

10

Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.

de Fijter CW, Verbrugh HA, Heezius HC, van der Meulen J, Oe PL, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: van der meulen j. J Antimicrob Chemother. 1990 Oct;26(4):525-32. doi: 10.1093/jac/26.4.525. J Antimicrob Chemother. 1990. PMID: 2254222 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

899 results

Search Page

Filters